Baptist Health Breaks Ground on New Home of Kenneth C Griffin Neuroscience Institute

• by

• October 12, 2026

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort

• September 30, 2026

• 3 min

Looking Beyond Symptoms in Psychiatric Drug Development

Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace

• October 15, 2026

• 10 min

Weekly hippocampal diffusion changes during partial-brain radiation therapy for high-grade glioma: associations with dose and early memory change

• by Ory Haisraely, Bikash Panthi, Kyle Richard Noll, Eleni Konstantinopoulou, Andrew Elliott, Sara Thrower, Holly Langshaw, Wasif Talpur, Catherine Sullaway, Todd Swanson, Chenyang Wang, Martin C. Tom, Thomas Beckham, Wen Jiang, Debra Nana Yeboa, Mary Frances McAleer, Amol Ghia, Susan Lynne McGovern, Jing Li, Jeffrey Scott Wefel, Caroline Chung

• October 13, 2026